Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2011
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
P Bossi, E Orlandi, C Bergamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
R Granata, R Miceli, E Orlandi, et al.
ESMO Open
|
August 25, 2023
Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022]
C van Herpen, V Vander Poorten, A Skalova, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 14, 2026
Particle Beam Re-irradiation in Oligo Recurrent Gynecological Malignancies
A Barcellini, A Vai, G Fontana, et al.
ESMO Open
|
December 25, 2022
Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up
C van Herpen, V Vander Poorten, A Skalova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
W van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
S Cavalieri, F Perrone, R Miceli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P Bossi, R Miceli, L D Locati, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L D Locati, F Perrone, B Cortelazzi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Oral Oncology
|
September 23, 2008
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
L D Locati, P Bossi, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2011
Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer
P Bossi, E Orlandi, C Bergamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 26, 2011
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
R Granata, R Miceli, E Orlandi, et al.
ESMO Open
|
August 25, 2023
Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022]
C van Herpen, V Vander Poorten, A Skalova, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 14, 2026
Particle Beam Re-irradiation in Oligo Recurrent Gynecological Malignancies
A Barcellini, A Vai, G Fontana, et al.
ESMO Open
|
December 25, 2022
Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up
C van Herpen, V Vander Poorten, A Skalova, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 17, 2019
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma
W van Boxtel, L D Locati, A C H van Engen-van Grunsven, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
S Cavalieri, F Perrone, R Miceli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P Bossi, R Miceli, L D Locati, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
L D Locati, F Perrone, B Cortelazzi, et al.
Page
of 4